Promise Tracker
0 delivered, 0 close, 3 missed.
View Promises →Everest Kanto Cylinder reported Q2 FY26 consolidated revenue of ₹360 crore and EBITDA of ₹42.9 crore (11.9% margin).
✓ Verified against BSE filing
Everest Kanto Cylinder reported Q2 FY26 consolidated revenue of ₹360 crore and EBITDA of ₹42.9 crore (11.9% margin). PAT stood at ₹13.7 crore. The CNG segment faced temporary softness due to BS6 transition in the automotive industry, which has since normalized. Industrial segment performed in line. The US business saw lower dispatches due to order-driven nature. Management guided EBITDA margins of 12-14% for the full year. Expansion at Mundra (₹130 crore spent, ₹30 crore balance) and Egypt (₹86 crore spent, ₹40 crore balance) is on track, with Egypt trial production expected by January 2026 and Mundra by March 2026. Combined order book is ₹1,000 crore executable over 12 months. Risks include GST litigation and potential forex penalty recurrence.
एवरेस्ट कांटो सिलेंडर ने दूसरी तिमाही में 360 करोड़ रुपये की कमाई और 42.9 करोड़ रुपये का मुनाफा (11.9% मार्जिन) बताया। शुद्ध मुनाफा 13.7 करोड़ रुपये रहा। सीएनजी कारोबार में कमजोरी थी क्योंकि ऑटो उद्योग नए उपकरणों (BS6) पर शिफ्ट हो रहा था, लेकिन अब यह सामान्य हो गया। औद्योगिक कारोबार ठीक रहा। अमेरिका में ऑर्डर मिलने पर ही माल भेजा गया। कंपनी को पूरे साल 12-14% मार्जिन की उम्मीद है। मुंद्रा (130 करोड़ खर्च, 30 करोड़ बाकी) और मिस्र (86 करोड़ खर्च, 40 करोड़ बाकी) में विस्तार चल रहा है। मिस्र में जनवरी 2026 और मुंद्रा में मार्च 2026 तक ट्रायल उत्पादन शुरू होगा। कुल ऑर्डर 1,000 करोड़ रुपये का है, जो 12 महीने में पूरा होगा। जोखिमों में जीएसटी विवाद और विदेशी मुद्रा जुर्माना शामिल है।
0 delivered, 0 close, 3 missed.
View Promises →GST litigation uncertainty
View Risks →Full transcript text is available on this route.
Read Transcript →Total order book across all locations, executable over next 12 months.
Order book for US operations, execution timeline 12-18 months.
Current utilization rate for standalone business; potential to increase by 20%.
Capital expenditure incurred on Egypt plant; balance ₹40 crore remains.
Management expects full-year EBITDA margins to be in the range of 12-14%.
The Mundra plant is expected to be commercialized by March 2026.
Management indicated a revenue target range for standalone business, though exact figure was unclear.
The Egypt facility is expected to begin trial production by January 2026.
Management expects India EBITDA margins to be in the range of 13-14% on a conservative basis, though they strive for higher.
Management guided for 10-15% revenue growth in India business for FY26.
The Mundra facility is expected to start commercial production just before the close of FY26.
The company has received GST demands and is awaiting government response; outcome and timeline are uncertain.
A ₹11 crore penalty was incurred for shortfall in net foreign exchange earnings; similar penalties may arise in future assessments.
Gross margins declined due to lower volumes in high-margin products; mix shift could continue to pressure margins.
The company faces a GST dispute with a contingent liability of ₹352 crore, roughly 30% of net worth. Management is confident of a favorable outcome but hearing date is not yet fixed.
The UAE business is facing certain headwinds and is expected to remain moderate in the coming quarters.
India margins improved sharply to 17.2% in Q1, but management guided for a more conservative 13-14% going forward, indicating the high margin may not be sustainable.
Management expects full-year EBITDA margins to be in the range of 12-14%.
The company has received GST demands and is awaiting government response; outcome and timeline are uncertain.
View Risks →